Clinical efficacy observation of TCM in the prevention and treatment of macronodular cirrhosis (precancerous lesions)

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1.Patients with chronic hepatitis B cirrhosis who meet the diagnostic criteria;
•2.Hepatic regenerative nodules (> 3 mm) were detected by B-mode ultrasonography and MRI.
•3.Age ranges from 18 to 65 years, gender is not limited.
•4.Sign informed consent.

•(1) Patients with cirrhosis caused by other hepatophilic virus infection or other pathogenic factors;
•(2) The presence or suspected presence of primary hepatocellular carcinoma lesions was detected by B-mode ultrasonography and MRI.
•(3) The patients with decompensated cirrhosis, such as those with Child-Pugh C grade > 12 points, had upper gastrointestinal bleeding, hepatic encephalopathy, intractable ascites, hemorrhagic tendency, hepatorenal syndrome and primary hepatocellular carcinoma in the past six months.
•(4) Patients with severe primary diseases of heart, kidney, lung, endocrine, blood, metabolism and gastrointestinal tract; or psychiatric patients.
•(5) Pregnant women or breast-feeding women who are willing to have children in the near future.

发起方

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine